Geometric Self-Supervised Learning: A Novel AI Approach Towards Quantitative and Explainable Diabetic Retinopathy Detection.

IF 3.8 3区 医学 Q2 ENGINEERING, BIOMEDICAL Bioengineering Pub Date : 2025-02-06 DOI:10.3390/bioengineering12020157
Lucas Pu, Oliver Beale, Xin Meng
{"title":"Geometric Self-Supervised Learning: A Novel AI Approach Towards Quantitative and Explainable Diabetic Retinopathy Detection.","authors":"Lucas Pu, Oliver Beale, Xin Meng","doi":"10.3390/bioengineering12020157","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Diabetic retinopathy (DR) is the leading cause of blindness among working-age adults. Early detection is crucial to reducing DR-related vision loss risk but is fraught with challenges. Manual detection is labor-intensive and often misses tiny DR lesions, necessitating automated detection.</p><p><strong>Objective: </strong>We aimed to develop and validate an annotation-free deep learning strategy for the automatic detection of exudates and bleeding spots on color fundus photography (CFP) images and ultrawide field (UWF) retinal images.</p><p><strong>Materials and methods: </strong>Three cohorts were created: two CFP cohorts (Kaggle-CFP and E-Ophtha) and one UWF cohort. Kaggle-CFP was used for algorithm development, while E-Ophtha, with manually annotated DR-related lesions, served as the independent test set. For additional independent testing, 50 DR-positive cases from both the Kaggle-CFP and UWF cohorts were manually outlined for bleeding and exudate spots. The remaining cases were used for algorithm training. A multiscale contrast-based shape descriptor transformed DR-verified retinal images into contrast fields. High-contrast regions were identified, and local image patches from abnormal and normal areas were extracted to train a U-Net model. Model performance was evaluated using sensitivity and false positive rates based on manual annotations in the independent test sets.</p><p><strong>Results: </strong>Our trained model on the independent CFP cohort achieved high sensitivities for detecting and segmenting DR lesions: microaneurysms (91.5%, 9.04 false positives per image), hemorrhages (92.6%, 2.26 false positives per image), hard exudates (92.3%, 7.72 false positives per image), and soft exudates (90.7%, 0.18 false positives per image). For UWF images, the model's performance varied by lesion size. Bleeding detection sensitivity increased with lesion size, from 41.9% (6.48 false positives per image) for the smallest spots to 93.4% (5.80 false positives per image) for the largest. Exudate detection showed high sensitivity across all sizes, ranging from 86.9% (24.94 false positives per image) to 96.2% (6.40 false positives per image), though false positive rates were higher for smaller lesions.</p><p><strong>Conclusions: </strong>Our experiments demonstrate the feasibility of training a deep learning neural network for detecting and segmenting DR-related lesions without relying on their manual annotations.</p>","PeriodicalId":8874,"journal":{"name":"Bioengineering","volume":"12 2","pages":""},"PeriodicalIF":3.8000,"publicationDate":"2025-02-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11852169/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Bioengineering","FirstCategoryId":"5","ListUrlMain":"https://doi.org/10.3390/bioengineering12020157","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ENGINEERING, BIOMEDICAL","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Diabetic retinopathy (DR) is the leading cause of blindness among working-age adults. Early detection is crucial to reducing DR-related vision loss risk but is fraught with challenges. Manual detection is labor-intensive and often misses tiny DR lesions, necessitating automated detection.

Objective: We aimed to develop and validate an annotation-free deep learning strategy for the automatic detection of exudates and bleeding spots on color fundus photography (CFP) images and ultrawide field (UWF) retinal images.

Materials and methods: Three cohorts were created: two CFP cohorts (Kaggle-CFP and E-Ophtha) and one UWF cohort. Kaggle-CFP was used for algorithm development, while E-Ophtha, with manually annotated DR-related lesions, served as the independent test set. For additional independent testing, 50 DR-positive cases from both the Kaggle-CFP and UWF cohorts were manually outlined for bleeding and exudate spots. The remaining cases were used for algorithm training. A multiscale contrast-based shape descriptor transformed DR-verified retinal images into contrast fields. High-contrast regions were identified, and local image patches from abnormal and normal areas were extracted to train a U-Net model. Model performance was evaluated using sensitivity and false positive rates based on manual annotations in the independent test sets.

Results: Our trained model on the independent CFP cohort achieved high sensitivities for detecting and segmenting DR lesions: microaneurysms (91.5%, 9.04 false positives per image), hemorrhages (92.6%, 2.26 false positives per image), hard exudates (92.3%, 7.72 false positives per image), and soft exudates (90.7%, 0.18 false positives per image). For UWF images, the model's performance varied by lesion size. Bleeding detection sensitivity increased with lesion size, from 41.9% (6.48 false positives per image) for the smallest spots to 93.4% (5.80 false positives per image) for the largest. Exudate detection showed high sensitivity across all sizes, ranging from 86.9% (24.94 false positives per image) to 96.2% (6.40 false positives per image), though false positive rates were higher for smaller lesions.

Conclusions: Our experiments demonstrate the feasibility of training a deep learning neural network for detecting and segmenting DR-related lesions without relying on their manual annotations.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
求助全文
约1分钟内获得全文 去求助
来源期刊
Bioengineering
Bioengineering Chemical Engineering-Bioengineering
CiteScore
4.00
自引率
8.70%
发文量
661
期刊介绍: Aims Bioengineering (ISSN 2306-5354) provides an advanced forum for the science and technology of bioengineering. It publishes original research papers, comprehensive reviews, communications and case reports. Our aim is to encourage scientists to publish their experimental and theoretical results in as much detail as possible. All aspects of bioengineering are welcomed from theoretical concepts to education and applications. There is no restriction on the length of the papers. The full experimental details must be provided so that the results can be reproduced. There are, in addition, four key features of this Journal: ● We are introducing a new concept in scientific and technical publications “The Translational Case Report in Bioengineering”. It is a descriptive explanatory analysis of a transformative or translational event. Understanding that the goal of bioengineering scholarship is to advance towards a transformative or clinical solution to an identified transformative/clinical need, the translational case report is used to explore causation in order to find underlying principles that may guide other similar transformative/translational undertakings. ● Manuscripts regarding research proposals and research ideas will be particularly welcomed. ● Electronic files and software regarding the full details of the calculation and experimental procedure, if unable to be published in a normal way, can be deposited as supplementary material. ● We also accept manuscripts communicating to a broader audience with regard to research projects financed with public funds. Scope ● Bionics and biological cybernetics: implantology; bio–abio interfaces ● Bioelectronics: wearable electronics; implantable electronics; “more than Moore” electronics; bioelectronics devices ● Bioprocess and biosystems engineering and applications: bioprocess design; biocatalysis; bioseparation and bioreactors; bioinformatics; bioenergy; etc. ● Biomolecular, cellular and tissue engineering and applications: tissue engineering; chromosome engineering; embryo engineering; cellular, molecular and synthetic biology; metabolic engineering; bio-nanotechnology; micro/nano technologies; genetic engineering; transgenic technology ● Biomedical engineering and applications: biomechatronics; biomedical electronics; biomechanics; biomaterials; biomimetics; biomedical diagnostics; biomedical therapy; biomedical devices; sensors and circuits; biomedical imaging and medical information systems; implants and regenerative medicine; neurotechnology; clinical engineering; rehabilitation engineering ● Biochemical engineering and applications: metabolic pathway engineering; modeling and simulation ● Translational bioengineering
期刊最新文献
Inflammatory Cell-Targeted Delivery Systems for Myocardial Infarction Treatment. Biomedical Applications of Big Data and Artificial Intelligence. An Innovative Coded Language for Transferring Data via a Haptic Thermal Interface. Development of Mathematical Model for Understanding Microcirculation in Diabetic Foot Ulcers Based on Ankle-Brachial Index. Different Oral Appliance Designs Demonstrate Different Rates of Efficacy for the Treatment of Obstructive Sleep Apnea: A Review Article.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1